{"id":"chimerivax-wn02-low-dose","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2108580","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inducing an immune response against the dengue virus, providing protection against dengue fever. This is achieved through the use of a live, attenuated dengue virus strain. The vaccine is designed to stimulate the body's immune system to produce antibodies and immune cells that can recognize and fight the dengue virus.","oneSentence":"ChimeriVax-WN02 Low Dose is a vaccine that targets the dengue virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:26:30.866Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of dengue fever"}]},"trialDetails":[{"nctId":"NCT00442169","phase":"PHASE2","title":"Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2005-12","conditions":"West Nile Fever","enrollment":208},{"nctId":"NCT00746798","phase":"PHASE2","title":"Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2008-10","conditions":"West Nile Fever","enrollment":479}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ChimeriVax-WN02 Low Dose","genericName":"ChimeriVax-WN02 Low Dose","companyName":"Sanofi Pasteur, a Sanofi Company","companyId":"sanofi","modality":"Biologic","firstApprovalDate":"","aiSummary":"ChimeriVax-WN02 Low Dose is a vaccine that targets the dengue virus. Used for Prevention of dengue fever.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}